ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
118.37
+3.40 (2.96%)
At close: Apr 2, 2026, 4:00 PM EDT
118.90
+0.53 (0.45%)
After-hours: Apr 2, 2026, 7:56 PM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 67 employees as of September 30, 2025. The number of employees increased by 5 or 8.06% compared to the same quarter last year.
Employees
67
Change
5
Growth
8.06%
Revenue / Employee
$80,086
Profits / Employee
-$5,889,923
Market Cap
9.27B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 67 | 5 | 8.06% | 67 | 0 |
| Jun 30, 2025 | 69 | 7 | 11.29% | 69 | 0 |
| Mar 31, 2025 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Jun 30, 2024 | 62 | - | - | 62 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 24 | -3 | -11.11% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Exelixis | 1,077 |
| Axsome Therapeutics | 925 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
ABVX News
- 3 days ago - Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies - GlobeNewsWire
- 4 days ago - Abivax: Obefazimod's Strategic Scarcity Drives Optionality (Maintaining Buy) - Seeking Alpha
- 9 days ago - 2 Healthcare Stocks That Could Soar Over the Next 5 Years - The Motley Fool
- 11 days ago - Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears - Benzinga
- 12 days ago - Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC - CNBC
- 16 days ago - 2 Healthcare Stocks to Buy Before They Get Bought Out - The Motley Fool
- 18 days ago - AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights - Seeking Alpha
- 20 days ago - Abivax: Maintaining 'Strong Buy' On Buyout Speculation And Obefazimod Advancement - Seeking Alpha